Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Molecular Imaging and Biology|August 15, 2018
Combined Early and Late [68Ga]PSMA-HBED-CC PET Scans Improve Lesion Detectability in Biochemical Recurrence of Prostate Cancer with Low PSA LevelsM Hohberg, C Kobe, P Täger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2009
FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive valueJ Markova, C Kobe, M Skopalova, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2010
Evaluation of interim PET response criteria in paediatric Hodgkin's lymphoma--results for dedicated assessment criteria in a blinded dual-centre readC Furth, H Amthauer, H Hautzel, et al.
Acta Biomaterialia|December 31, 2021
Tapping basement membrane motifs: Oral junctional epithelium for surface-mediated soft tissue attachment to prevent failure of percutaneous devicesNicholas G Fischer, Alexandra C Kobe, Jinhong Dai, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 16, 2025
Early image acquisition 68Ga-FAPI-46-PET/CT in prone position is promising in the workup of rectosigmoid and anal carcinomaD Ufton, J Heilinger, H Weis, et al.
Nuklearmedizin. Nuclear Medicine|August 10, 2013
Interim PET response criteria in paediatric non-Hodgkin's lymphoma. Results from a retrospective multicenter readingC Furth, A S Erdrich, I G Steffen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2018
Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18C-A Voltin, H Goergen, C Baues, et al.
Nuklearmedizin. Nuclear Medicine|February 4, 2010
Development of anti-CD30 radioimmunoconstructs (RICs) for treatment of Hodgkin's lymphoma. Studies with cell lines and animal studiesMarkus Dietlein, S M Börner, T Fischer, et al.
Nuklearmedizin. Nuclear Medicine|September 22, 2015
Concordance in the interpretation of PET after chemotherapy in advanced stage Hodgkin lymphomaC Kobe, G Kuhnert, H Haverkamp, et al.
Lung Cancer (Amsterdam, Netherlands)|April 6, 2013
Complete metabolic response in a patient with repeatedly relapsed non-small cell lung cancer harboring ROS1 gene rearrangement after treatment with crizotinibM Bos, M Gardizi, H U Schildhaus, et al.
Pageof 4